Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

SELL
$56.27 - $73.77 $618 - $811
-11 Reduced 40.74%
16 $1.11 Million
Q4 2023

Apr 04, 2024

BUY
$59.06 - $75.72 $649 - $832
11 Added 68.75%
27 $1.34 Million
Q1 2023

Apr 04, 2024

SELL
$47.19 - $70.77 $519 - $778
-11 Reduced 40.74%
16 $1.09 Million
Q4 2022

Apr 04, 2024

BUY
$30.35 - $53.15 $819 - $1,435
27 New
27 $1.34 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.02B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Financial Synergies Wealth Advisors, Inc. Portfolio

Follow Financial Synergies Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Synergies Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Synergies Wealth Advisors, Inc. with notifications on news.